Evotec SE's stock has declined over 30% in a single day, marking a 5-year decline of over 56%. See why I think EVO stock is a ...

HAMBURG, GERMANY / ACCESSWIRE / April 23, 2024 / The Supervisory Board of (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: ...

Adjusted Group EBITDA at €66.4M (2022: €101.7M), adjusted for one-off effects related to the recovery from the severe ...

Hamburg, Germany, 24 April 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today reported financial results and corporate updates for the fiscal year ...

HAMBURG, GERMANY / ACCESSWIRE / April 17, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ:EVO) will announce its financial results for 2023 on Wednesday, 24 ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

BAYER AND EVOTEC UPDATE FOCUS OF THEIR COLLABORATION TO CARDIOVASCULAR DISEASESSTRATEGIC ALLIANCE LEVERAGES HUMAN INDUCED PLURIPOTENT STEM CELL DISEASE MODELLING FOR IDENTIFICATION OF NOVEL TARGETSJOI ...

Q4 2023 Earnings Call April 24, 2024 Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were ...

EQS-News: EVOTEC SE / Key word (s): Personnel Evotec SE appoints Dr Christian Wojczewski as Chief Executive Officer 23.04.2024 / 20:40 CET/CEST The issuer is solely responsible for the content of ...

Ladies and gentlemen, welcome to the Evotec SE Annual Report 2023 Conference Call. I’m Moritz Nikolaus, call operator. I would like to remind you that all participants will be in a listen-only ...

Thank you. Volker Braun: Let’s try from a few angles, Peter. So, let’s start in the area of Just-Evotec Biologics. The last year I’ve seen is that we reached €850 million. I mean ...